Sponsor

The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD)

Award

Up to $2,500,000 over 1 – 3 years, based on stage and scope of the trial.

Due Date

Letter of Intent due September 30th, 2024. Full Proposal due December 9th, 2024.